Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retroviral vectors for persistent expression in vivo.

R K Naviaux1, I M Verma

  • 1Molecular Biology and Virology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92186-5800.

Current Opinion in Biotechnology
|October 1, 1992
PubMed
Summary

Retroviral vectors offer safe gene delivery to dividing cells. Novel tissue-specific enhancers now improve gene expression in vivo, advancing gene therapy applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice.

Psychopharmacology·2017
Same author

Identification of therapeutic targets for glioblastoma by network analysis.

Oncogene·2015
Same author

Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy.

Translational psychiatry·2014
Same author

Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases.

Oncogene·2011
Same author

NF-kappaB and the regulation of hematopoiesis.

Cell death and differentiation·2006
Same author

Ultrafast nanolaser flow device for detecting cancer in single cells.

Biomedical microdevices·2006

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Retroviral vectors are established tools for gene delivery into dividing cells.
  • Historically, poor in vivo gene expression limited retroviral vector efficacy.
  • Gene therapy aims to treat diseases by introducing therapeutic genes.

Purpose of the Study:

  • To review the biology and applications of retroviral vectors in gene therapy.
  • To highlight advancements in overcoming gene expression limitations.
  • To discuss the role of tissue-specific enhancers.

Main Methods:

  • Review of existing literature on retroviral vectors.
  • Analysis of gene expression data in vivo.
  • Discussion of enhancer elements and their function.

Main Results:

  • Retroviral vectors are safe and efficient for gene transfer into dividing cells.
  • Tissue-specific enhancers have successfully improved in vivo gene expression.
  • These advancements broaden the practical applications of retroviral vectors.

Conclusions:

  • Retroviral vectors are a viable platform for gene therapy.
  • Improved gene expression is critical for therapeutic success.
  • Tissue-specific enhancers represent a key innovation in vector design.

Related Experiment Videos